Drug Type CAR-T |
Synonyms- |
Target |
Action modulators |
Mechanism CCL19 modulators(C-C motif chemokine ligand 19 modulators), IL-7 modulators(interleukin 7 modulators), Immunologic cytotoxicity |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-cell lymphoma refractory | Phase 1 | China | 20 Jun 2024 | |
| Mantle-Cell Lymphoma | Phase 1 | China | 20 Jun 2024 | |
| Mediastinal large B-cell lymphoma | Phase 1 | China | 20 Jun 2024 |





